Flegal KM, et al.. Prevalence and trends in obesity among U.S. adults, 1999–2008. JAMA 2010; 303:235–241.
http://www.who.int/mediacentre/factsheets/fs311/en/(Accessed August 17, 2011)
Wang Y, et al.. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008; 73:19–33.
Preble W. Obesity: observations on one thousand cases. Boston Med Surg J 1923; 188:617–621.
Henegar JR, et al.. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001; 12:1211–1217.
Serra A, et al.. Renal injury in the extremely obese patients with normal renal function. Kidney Int 2008; 73:947–955.
Kambham N, et al.. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 59:1498–1509.
Hsu CY, et al.. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144:21–28.
Iseki K, et al.. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65:1870–1876.
Fox CS, et al.. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291:844–850.
Bonnet F, et al.. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001; 37:720–727.
Abitbol CL, et al.. Obesity and preterm birth: additive risks in the progression of kidney disease in children. Pediatr Nephrol 2009; 24:1363–1370.
Chagnac A, et al.. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003; 14:1480–1486.
Afshinnia F, et al.. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2009; 25:1173–1183.
Mallamaci F, et al.. ACE inhibition is renoprotective among obese patients with proteinuria. J Am Soc Nephrol 2011; 22:1122–1128.